1. Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea”

   • Daniel Gil

   Letter to the Editor Open access 04 August 2018 Pages: 165 - 166

2. Critical Review of the Use of Second-Generation Antipsychotics in Obsessive–Compulsive and Related Disorders

   • Dongmi Kim
   • Nicole L. Ryba
   • Ligia Westrich

   Review Article Open access 31 August 2018 Pages: 167 - 189

3. Octreotide Use in Neonates: A Case Series

   • Syed Ahmed Zaki
   • Mohan B. Krishnamurthy
   • Atul Malhotra

   Original Research Article Open access 15 June 2018 Pages: 191 - 198

4. Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir

   • Magda Opsomer
   • Dessislava Dimitrova
   • Katia Boven

   Original Research Article Open access 10 July 2018 Pages: 199 - 210

   

5. The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients

   • Vance J. Bray
   • Aaron Broadwell
   • Raphael J. DeHoratius

   Original Research Article Open access 28 July 2018 Pages: 211 - 219

   

6. Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers

   • Richard Dimelow
   • James G. Wright
   • Shampa Das

   Original Research Article Open access 27 July 2018 Pages: 221 - 230

   

7. Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis

   • Teruko Nakamura
   • Taisei Fujisaki
   • Yuji Ikeda

   Original Research Article Open access 10 August 2018 Pages: 231 - 235

   

8. New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal Impairment

   • Valeria Tellone
   • Paola Coppola
   • Serena Tongiani

   Original Research Article Open access 27 August 2018 Pages: 237 - 245

   

9. Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication

   • Jordi Guitart
   • María Isabel Vargas
   • Almudena Sanz

   Correction Open access 09 July 2018 Pages: 247 - 248

10. Correction to: Evaluation of Cardiovascular Disease Risk in HIV‑1–Infected Patients Treated with Darunavir

    • Magda Opsomer
    • Dessislava Dimitrova
    • Katia Boven

    Correction Open access 06 August 2018 Pages: 249 - 250